Bayer, Baxter, RPR, Alpha Therapeutic offer $100,000 per claimant to HIV-infected hemophiliac plaintiffs.
Executive Summary
BAYER, BAXTER, RPR, ALPHA THERAPEUTIC OFFER $100,000 PER HEMOPHILIA CLAIMANT to a class of approximately 6,000 plaintiffs who allege that the companies negligently sold them blood-clotting products, Factor VIII and/or Factor IX, derived from HIV-tainted human blood plasma. The settlement offer is subject to a $640 mil. cap, including administrative costs and attorneys' fees. The class action dates to 1993.